Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer With Bone Metastasis”

236 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 236 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Testing effectiveness (Phase 2)Study completedNCT01599793
What this trial is testing

Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer

Who this might be right for
Bone MetastasesCastrate-resistant Prostate CancerRecurrent Prostate Cancer+1 more
University of Chicago 19
Testing effectiveness (Phase 2)Study completedNCT01106352
What this trial is testing

Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Bone MetastasesCastration-Resistant Prostate Cancer
Bayer 70
Not applicableEnded earlyNCT03111914
What this trial is testing

Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate Cancer

Who this might be right for
Dual Energy CT (DECT)Prostate Cancer
Duke University 7
Testing effectiveness (Phase 2)Ended earlyNCT04754425
What this trial is testing

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaCastration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted AgentsMetastatic Malignant Neoplasm in the Bone+5 more
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00554918
What this trial is testing

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
University Hospital Birmingham 300
Testing effectiveness (Phase 2)Ended earlyNCT01703065
What this trial is testing

Cabozantinib in Men With Castration-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateCastration-resistant Prostate CancerRecurrent Prostate Cancer+2 more
University of Washington 9
Not applicableStudy completedNCT04681144
What this trial is testing

Learn More About How Radium-223 Affects the Quality of Life of Colombian Patients With Prostate Cancer That Has Not Responded to Testosterone Lowering Treatment and Has Spread to the Bones, and to Better Understand Its Safety

Who this might be right for
Prostate Cancer
Bayer 103
Testing effectiveness (Phase 2)Study completedNCT02601014
What this trial is testing

Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7

Who this might be right for
Prostate CancerRecurrent Prostate CarcinomaStage IV Prostate Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Testing effectiveness (Phase 2)Ended earlyNCT04616547
What this trial is testing

Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Adenocarcinoma+3 more
National Cancer Institute (NCI) 1
Large-scale testing (Phase 3)Study completedNCT00003162
What this trial is testing

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Who this might be right for
Breast CancerMetastatic CancerPain+1 more
Radiation Therapy Oncology Group 949
Large-scale testing (Phase 3)Study completedNCT00286091
What this trial is testing

Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Amgen 1,435
Large-scale testing (Phase 3)Study completedNCT01419717
What this trial is testing

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

Who this might be right for
Bone Metastases in Men With Hormone-Refractory Prostate CancerBone Metastases in Subjects With Advanced Breast Cancer
Amgen 129
Large-scale testing (Phase 3)Study completedNCT00003884
What this trial is testing

Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone

Who this might be right for
Hypercalcemia of MalignancyLung CancerMetastatic Cancer+2 more
Novartis 600
Testing effectiveness (Phase 2)Study completedNCT00936975
What this trial is testing

Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 18
Post-approval studies (Phase 4)Study completedNCT00219219
What this trial is testing

Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases

Who this might be right for
Prostate Cancer
Novartis
Not applicableStudy completedNCT01233557
What this trial is testing

Biomarkers of Bone Resorption in Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
University of Aberdeen 40
Not applicableStudy completedNCT01501630
What this trial is testing

Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer

Who this might be right for
Prostate Cancer
Assistance Publique - Hôpitaux de Paris 112
Large-scale testing (Phase 3)Study completedNCT00925600
What this trial is testing

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Who this might be right for
CancerCataractLow Bone Mineral Density+3 more
Amgen 769
Load More Results